Imunon, Inc. Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31)
Imunon, Inc. (IMNN) reported Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) of 11.75% for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentInterestRateStatedPercentageRateRangeMaximum · last filed 2012-11-09
- 2012-09-30: Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) 9 month 11.75%.
- 2012-06-30: Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) 6 month 11.75%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) 6 month | Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) 9 month |
|---|---|---|
| 2012-09-30 | 11.75% 10-Q · filed 2012-11-09 | |
| 2012-06-30 | 11.75% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |